Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Clinical trials update: RENEWAL (RENAISSANCE and RECOVER) and ATTACH.

Literature DB >> 12167397

Clinical trials update: RENEWAL (RENAISSANCE and RECOVER) and ATTACH.

A P Coletta¹, A L Clark, P Banarjee, J G F Cleland.

Abstract

This article continues a series of reports on recent research developments in the field of heart failure. Reports of two key presentations made at the European Society of Cardiology Heart Failure Update meeting held in Oslo, Norway from 8 to 11 June 2002, are included in this article. Summaries of the results of the RENEWAL (RENAISSANCE and RECOVER) and ATTACH studies, presented at the Hot Line sessions held during the meeting are reported.

Entities: Disease

Mesh：

Substances：

Year: 2002 PMID： 12167397 DOI： 10.1016/s1388-9842(02)00121-6

Source DB: PubMed Journal: Eur J Heart Fail ISSN： 1388-9842 Impact factor: 15.534

Keyword Cloud
Cited

26 in total

1. Dose escalation of infliximab in clinical practice: improvements seen may be explained by a regression-like effect.

Authors: R F van Vollenhoven; S Brannemark; L Klareskog
Journal: Ann Rheum Dis Date: 2004-04 Impact factor: 19.103

2. [Recommendations for the management of ankylosing spodylitis after ASAS/EULAR. Evaluation in the German language area].

Authors: J Braun; J Zochling; E Märker-Hermann; G Stucki; H Böhm; M Rudwaleit; H Zeidler; J Sieper
Journal: Z Rheumatol Date: 2006-12 Impact factor: 1.372

Review 3. Current evidence for the management of ankylosing spondylitis: a systematic literature review for the ASAS/EULAR management recommendations in ankylosing spondylitis.

Authors: J Zochling; D van der Heijde; M Dougados; J Braun
Journal: Ann Rheum Dis Date: 2005-08-26 Impact factor: 19.103

4. ASAS/EULAR recommendations for the management of ankylosing spondylitis.

Authors: J Zochling; D van der Heijde; R Burgos-Vargas; E Collantes; J C Davis; B Dijkmans; M Dougados; P Géher; R D Inman; M A Khan; T K Kvien; M Leirisalo-Repo; I Olivieri; K Pavelka; J Sieper; G Stucki; R D Sturrock; S van der Linden; D Wendling; H Böhm; B J van Royen; J Braun
Journal: Ann Rheum Dis Date: 2005-08-26 Impact factor: 19.103

Clinical trials update: RENEWAL (RENAISSANCE and RECOVER) and ATTACH.

1. Dose escalation of infliximab in clinical practice: improvements seen may be explained by a regression-like effect.

2. [Recommendations for the management of ankylosing spodylitis after ASAS/EULAR. Evaluation in the German language area].

Review 3. Current evidence for the management of ankylosing spondylitis: a systematic literature review for the ASAS/EULAR management recommendations in ankylosing spondylitis.

4. ASAS/EULAR recommendations for the management of ankylosing spondylitis.

Review 5. Cardiovascular comorbidity in rheumatic diseases: a focus on heart failure.

Review 6. Unresolved issues in biologic therapy for rheumatoid arthritis.

Review 7. Cardiac Impairment in Rheumatoid Arthritis and Influence of Anti-TNFα Treatment.

8. Immune responsive resolvin D1 programs myocardial infarction-induced cardiorenal syndrome in heart failure.

Review 9. Mechanisms for cachexia in heart failure.

Review 10. Safety of tumour necrosis factor-alpha antagonists.